This webinar is a recorded presentation of a live broadcast and includes the presentation, handout, and the audience QA. If you would like continuing education credit for the webinar, click on the links in the table below to access the webinar + CME/CMLE or webinar + SAM.
Description: This webinar will act as an overview and update regarding the use of Tumor Mutational Burden (TMB) as a diagnostic and prognostic tool. Advances in massively parallel sequencing technologies has facilitated the large scale examination of the mutational profile of tumors. Best practices with regard to elaboration of these techniques is evolving as is the correlation of results with clinical outcomes. This presentation will provide additional information regarding the newest innovations as well as implications for TMB testing, interpretation, and reporting. Some clinical applications and challenges will be discussed.
Duration: 1 hr
Level of Instruction: Basic
This webinar is part 1 of a two-part series exploring the role of TMB testing in relationship to other tumor biomarkers as well as the standardization of TMB testing.
This program has been supported through an educational grant from Bristol-Myers Squibb.
Click on the links below to purchase continuing education credit.
* You may not submit SAMs and CME/CMLE credit for the same content.
You may also be interested in:
Note: Members of AMP can access many of the webinars at no cost or a deep discount. Join the AMP Family!
All sales are final. No refunds will be issued.
No digital files may be reproduced or transmitted in any form, by any means, electronic or mechanical. By purchasing a product, you agree to not share any of the course materials, including videos, downloadable slide presentations, outlines, manuscripts, etc. without explicit and written permission from AMP.
June 06, 2019
AMP Regular Member: $0.00
AMP Technologist Member: $0.00
AMP Associate Member: $0.00
Non-member Price: $0.00